Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China.
Saved in:
| Title: | Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China. |
|---|---|
| Authors: | Chen, Hongru1,2,3,4 (AUTHOR), Yu, Lu5 (AUTHOR), Liang, Fei6 (AUTHOR), Zhou, Yue1,2,3,4 (AUTHOR), Chu, Li1,2,3,4 (AUTHOR), Chu, Xiao1,2,3,4 (AUTHOR), Yang, Xi1,2,3,4 (AUTHOR), Zhang, Junhua1,2,3,4 (AUTHOR), Pang, Yechun1,2,3,4 (AUTHOR), Wang, Zezhou2,7 (AUTHOR), Yuan, Zhiyong5 (AUTHOR), Ni, Jianjiao1,2,3,4 (AUTHOR) nijianjiao8@sina.com, Zhu, Zhengfei1,2,3,4,8 (AUTHOR) fuscczzf@163.com |
| Source: | PLoS Medicine. 8/1/2025, Vol. 22 Issue 8, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
